Mild and moderate infections are common among patients with inflammatory bowel disease, with women having higher incidence ...

The environment is increasingly acknowledged to play a critical role in our risk of developing diseases, with 30,000 deaths attributed to air pollution alone in the UK each year. A new research centre ...

A new Medical Research Council Centre of Research Excellence (MRC CoRE) will investigate how the environment interacts with our immune system to ...

The environment is increasingly acknowledged to play a critical role in our risk of developing diseases, with 30,000 deaths ...

These five physicians are making significant contributions at the forefront of gastroenterology. If you’d like to nominate a physician, please email pnewitt@beckershealthcare.com. Bincy Abraham, MD Dr ...

The 24-year study of more than 1.2 million children in Denmark found that aluminum exposure didn't raise the risk of autism, asthma, or other chronic diseases. Other science and research news is on ...

Eli Lilly (NYSE:LLY) has won Health Canada approval for Omvoh (mirikizumab) in patients with Crohn’s disease, the company ...

Eli Lilly Canada Inc. (Lilly Canada) announced today that Health Canada has approved Omvoh® (mirikizumab) for CD, which will ...

A four-strain probiotic blend has shown promise in easing IBS symptoms in IBD patients without active inflammation, offering ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Inflammatory Bowel Disease often leaves patients in isolation, the result of constant pain and a constant need to be near a bathroom. For many, the debilitating physical ...

There's one main way to treat inflammatory bowel disease (IBD): Control inflammation by whipping the immune system into shape ...